At SOLTI we promote excellence in independent clinical research
Currently 60% of our pipeline are trials promoted by the group
Ready for the oncology of the future?
With a traslational-basis, our trials are grouped under three programs:
Clinical Trial Program
Phase I, II and III classical trials, proof-of-concept. Involving quite a large period of time, give us information on a drug’s efficacy.
Trials with no drug-intervention. Samples collection + correlative analysis of tumors and liquid biopsies. Looking for clinically-predictive biomarkers and mechanisms of resistance.
Very informative trials at a biological level. They take advantage of the period between the diagnosis and surgery to test new therapeutic strategies.